phospho stat2 tyr690 antibody (Cell Signaling Technology Inc)
Structured Review
Phospho Stat2 Tyr690 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 143 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+stat2+tyr690+antibody/Phospho-Stat2+(Tyr690)+Antibody/us12570711-1177-55-58
Average 95 stars, based on 143 article reviews
Images
Related Articles
Activity Assay:Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat1 (Tyr701) antibody (e.g., Clone D4A7; Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat1 (Tyr701) antibody (e.g., Clone D4A7; Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Control:Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat1 (Tyr701) antibody (e.g., Clone D4A7; Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-NF-κB p65 (Ser536) antibody (Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Article Title: Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy Article Snippet: In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using Phospho-Stat1 (Tyr701) antibody (e.g., Clone D4A7; Cell Signaling Technology; Danvers, MA) when exposed to or expressed in a test human T cell as compared to a control human T cell. .. In some embodiments, a selective NF-κB activator induces more than 20% (e.g., more than 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%) increase in NF-κB activity as measured by Phospho-IκBα (Ser32) antibody (e.g., 14D4, Clone Cell Signaling Technology; Danvers, MA) but less than 20% increase in the activity of the STAT pathway as measured using other:Article Title: Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer Article Snippet: The following antibodies were purchased from |

